SU2C

4 Apr 2019

Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

/

TagsBaylin, cancer, cancer research, Rothbart, SU2C, VARI, VARI-SU2C

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a...

ABOUT VAI

Established by Jay and Betty Van Andel in 1996, Van Andel Institute's goal is to have an impact world-wide on biomedical research and science education.

EMAIL UPDATES

Name
This field is for validation purposes and should be left unchanged.

RECENT NEWS

Graduate student spotlight: How molecular ‘punctuation marks’ influence cancer and other diseases
Van Andel Institute Graduate School’s Robert Vaughan receives prestigious career development award from National Cancer Institute
Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

Donate Contact Us Compliance EthicsPoint Intranet Privacy Policy Terms of Use